Moreover, although TP53 was the most frequently mutated gene in PSCC, the frequency of TP53 in our study cohort was similar to that in the lung adenocarcinoma data set (46%) but significantly lower than the frequency in PSC patients (74%) [49, 53]. Here, TP53 is linked to lung adenocarcinoma.